Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Ward

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Virology|December 23, 2004
Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotypeMonica M McNeal, Karol Sestak, Anthony H-C Choi, et al.
The Journal of Infectious Diseases|November 17, 2006
Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12Richard L Ward, Carl D Kirkwood, Donna S Sander, et al.
Virology|December 27, 2005
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgAMonica M McNeal, Susan C Stone, Mitali Basu, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Nonmedical costs associated with rotavirus disease requiring hospitalizationBrian P Lee, Parvin H Azimi, Mary Allen Staat, et al.
Journal of Virology|December 26, 2001
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)Monica M McNeal, John L VanCott, Anthony H C Choi, et al.
Vaccine|February 7, 2007
Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injectionAnthony H-C Choi, Kristi Smiley, Mitali Basu, et al.
The Journal of Infectious Diseases|June 8, 2004
Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccineRichard L Ward, David I Bernstein, Vicki E Smith, et al.
Vaccine|July 17, 2007
Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challengeMonica M McNeal, Mitali Basu, Judy A Bean, et al.
Journal of Paediatrics and Child Health|April 26, 2012
Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methodsDavid O Matson, Mary Allen Staat, Parvin Azimi, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccinePenelope H Dennehy, Rebecca C Brady, Scott A Halperin, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Virology|December 23, 2004
Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotypeMonica M McNeal, Karol Sestak, Anthony H-C Choi, et al.
The Journal of Infectious Diseases|November 17, 2006
Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12Richard L Ward, Carl D Kirkwood, Donna S Sander, et al.
Virology|December 27, 2005
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgAMonica M McNeal, Susan C Stone, Mitali Basu, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Nonmedical costs associated with rotavirus disease requiring hospitalizationBrian P Lee, Parvin H Azimi, Mary Allen Staat, et al.
Journal of Virology|December 26, 2001
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)Monica M McNeal, John L VanCott, Anthony H C Choi, et al.
Vaccine|February 7, 2007
Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injectionAnthony H-C Choi, Kristi Smiley, Mitali Basu, et al.
The Journal of Infectious Diseases|June 8, 2004
Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccineRichard L Ward, David I Bernstein, Vicki E Smith, et al.
Vaccine|July 17, 2007
Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challengeMonica M McNeal, Mitali Basu, Judy A Bean, et al.
Journal of Paediatrics and Child Health|April 26, 2012
Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methodsDavid O Matson, Mary Allen Staat, Parvin Azimi, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccinePenelope H Dennehy, Rebecca C Brady, Scott A Halperin, et al.
Pageof 5